Brief: Dawnrays Pharmaceutical (Holdings) Says Disposal Of Interests In A Joint Venture Company
09/02/2024 05:53
Feb 9 (Reuters) - Dawnrays Pharmaceutical (Holdings) Ltd
2348.HK :
* DISPOSAL OF INTERESTS IN A JOINT VENTURE COMPANY
* SEES NET GAIN (BEFORE TAX) OF RMB267 MILLION TO RMB285
MILLION
FROM DISPOSAL
* UNIT TO SELL 35% STAKE IN AD PHARMACEUTICALS FOR RMB267.4
MILLION
Source text for Eikon: ID:n11067738-1
Further company coverage: 2348.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dawnrays Pharmaceutical (Holdings)
See all newsBrief: Dawnrays Pharmaceutical Says Suzhou Dawnrays Commits To Invest Up To RMB100 Mln In Partnership
Brief: Dawnrays Pharmaceutical (Holdings) Final Dividend Of Hk$0.048 Per Share
Brief: Dawnrays Pharmaceutical Reports HY Net Income Attributable Of RMB104.6 MLN
Brief: Dawnrays Pharmaceutical (Holdings) Posts FY Profit Attributable Of Rmb564.9 Million
Brief: Dawnrays Pharmaceutical (Holdings) Appoints Yu Liwei To Act As CEO